Annual Drug Patent Expirations for EVZIO
Evzio is a drug marketed by Kaleo Inc and is included in two NDAs. There are thirty-three patents protecting this drug.
Drug patent litigation for EVZIO.
This drug has one hundred and forty patent family members in fifteen countries.
The generic ingredient in EVZIO is naloxone hydrochloride. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
